167 related articles for article (PubMed ID: 34771163)
1. Synthesis and Antiproliferative Activity of 2,4,6,7-Tetrasubstituted-2
Razmienė B; Řezníčková E; Dambrauskienė V; Ostruszka R; Kubala M; Žukauskaitė A; Kryštof V; Šačkus A; Arbačiauskienė E
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771163
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of N-aryl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-amines and their photodynamic properties in the human skin melanoma cell line G361.
Razmienė B; Vojáčková V; Řezníčková E; Malina L; Dambrauskienė V; Kubala M; Bajgar R; Kolářová H; Žukauskaitė A; Arbačiauskienė E; Šačkus A; Kryštof V
Bioorg Chem; 2022 Feb; 119():105570. PubMed ID: 34953323
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-mitotic activity of 2,4- or 2,6-disubstituted- and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines.
Milišiūnaitė V; Arbačiauskienė E; Řezníčková E; Jorda R; Malínková V; Žukauskaitė A; Holzer W; Šačkus A; Kryštof V
Eur J Med Chem; 2018 Apr; 150():908-919. PubMed ID: 29602037
[TBL] [Abstract][Full Text] [Related]
4. One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents.
Barghash RF; Eldehna WM; Kovalová M; Vojáčková V; Kryštof V; Abdel-Aziz HA
Eur J Med Chem; 2022 Jan; 227():113952. PubMed ID: 34731763
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anticancer assessment on human breast, liver and colon carcinoma cell lines and molecular modeling study using novel pyrazolo[4,3-c]pyridine derivatives.
Metwally NH; Deeb EA
Bioorg Chem; 2018 Apr; 77():203-214. PubMed ID: 29367077
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors.
Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA
Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel pyrazolo[3,4-b]pyridines as cis-restricted combretastatin A-4 analogues.
Jian XE; Yang F; Jiang CS; You WW; Zhao PL
Bioorg Med Chem Lett; 2020 Apr; 30(8):127025. PubMed ID: 32063430
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of pyrazolo[3,4-b]pyridines under microwave irradiation in multi-component reactions and their antitumor and antimicrobial activities - Part 1.
El-borai MA; Rizk HF; Abd-Aal MF; El-Deeb IY
Eur J Med Chem; 2012 Feb; 48():92-6. PubMed ID: 22178093
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity.
Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
[TBL] [Abstract][Full Text] [Related]
13. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents.
Nagender P; Naresh Kumar R; Malla Reddy G; Krishna Swaroop D; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2016 Sep; 26(18):4427-4432. PubMed ID: 27528432
[TBL] [Abstract][Full Text] [Related]
16. 3,5-Diaryl-1H-pyrazolo[3,4-b]pyridines as potent tubulin polymerization inhibitors: Rational design, synthesis and biological evaluation.
Zhai M; Liu S; Gao M; Wang L; Sun J; Du J; Guan Q; Bao K; Zuo D; Wu Y; Zhang W
Eur J Med Chem; 2019 Apr; 168():426-435. PubMed ID: 30831410
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel 1,2,3-triazole tagged pyrazolo[3,4-b]pyridine derivatives and their cytotoxic activity.
Kurumurthy C; Veeraswamy B; Sambasiva Rao P; Santhosh Kumar G; Shanthan Rao P; Loka Reddy V; Venkateswara Rao J; Narsaiah B
Bioorg Med Chem Lett; 2014 Feb; 24(3):746-9. PubMed ID: 24424132
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and bioevaluation of N-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-amines as tubulin polymerization inhibitors with anti-angiogenic effects.
Hao SY; Qi ZY; Wang S; Wang XR; Chen SW
Bioorg Med Chem; 2021 Feb; 31():115985. PubMed ID: 33421913
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
